Podcasts about precision health

When loss cracks your world open, what happens next? In this powerful episode of Everything Is Personal, Karin Clarke shares her journey through divorce, generational trauma, and the unimaginable loss of a child — and how that devastation led her to discover a healing framework built on rupture, void, and expansion. We explore why suppression creates repetition, why coping is not the same as healing, and how the void — the space most people avoid — is actually where transformation begins. If you've experienced grief, trauma, divorce, addiction in the family, or feel stuck in emotional pain, this conversation will help you understand what true healing requires. EndoDNA: Where Genetic Science Meets Actionable Patient Care EndoDNA bridges the gap between complex genomics and patient wellness. Our patented DNA analysis platforms and AI technology provide genetic insights that support and enhance your clinical expertise. Click here to check out to take control over your Personal Health & Wellness   Connect with EndoDNA on SOCIAL: IG | X | YOUTUBE | FB Connect with host, Len May, on IG     Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com for information about our collection and use of personal data for advertising.

Reflections on the Peter Attia/Epstein scandal; How to lower lp(a)—does diet help? What are bio-active peptides? Could they stave off kidney disease? Scientists just tested the fittest 81-year-old in the world—here's what they found; Media erroneously report that intermittent fasting is not effective for weight loss; Sugary drinks may stoke anxiety in teens; Omega-3s support kids' reading fluency and spelling scores; Surprising study shows saturated fats not harmful to kidneys.

In this episode, Dr. Greg Jones sits down with Dr. Sharon Hausman-Cohen, Chief Medical Officer of IntelliXX DNA, to explore how medical genomics is transforming the way we understand heart disease, brain health, inflammation, and metabolism. Most people think genetics stops at traits like eye color or ancestry. Genomics goes much deeper—analyzing how thousands of genes interact to influence cardiovascular risk, cognitive function, clotting tendencies, nutrient metabolism, and chronic inflammation.Dr. Hausman-Cohen explains why many direct-to-consumer DNA tests fall short, how incomplete interpretation can mislead patients, and why clinician-guided genomic analysis allows for truly personalized care. The conversation also dives into inflammation, methylation, homocysteine, cholesterol myths, caffeine metabolism, mitochondrial health, and women's unique clotting risks.Whether you're trying to reduce your risk of heart disease, improve mental clarity, or understand how your biology responds to diet, supplements, and medications—this episode offers a science-based roadmap for precision health.

Closing in on 300 episodes of The Made To Thrive Show, it's been an enriching and empowering  journey for me speaking to global experts and health heroes about their fields of expertise. So in honor of the 300 mark, I have put together a masterclass composed of the best insights for each of Made To Thrive's 7 Pillars To Thriving: purpose, community, sleep, nutrition, movement, self-quantification, and environment. Thriving - Pillar by Pillar distills the best of those conversations into one powerful series. Each episode is curated to help you not just understand a specific pillar — but how to take action to live it.This is Medicine 4.0 in action: preventative, proactive, personalized through data, and performance-enhancing. We believe sustainable health begins with awareness, and education is the foundation that transforms how we become aware of ourselves and the actions and habits that create our life. Only when we understand, can we identify both what's holding us back as well as the thriving that's possible. At the root of the word doctor is Latin for teacher. Through the Pillar by Pillar series, I hope each episode becomes a lesson about how to see health and wellness differently, and to empower you to take action, one intentional, educated step at a time.Self-Quantification Tracking your body and health metrics transforms abstract goals into actionable insights. Data from heart rate, HRV, fasting insulin, or sleep patterns helps you see what's working, what's not, and where to focus your energy. Awareness through measurement empowers better decision-making, moving from reactive to proactive health management.Featured Guests:Dr Jay WilesAri TullaDr Derek YachDr John ObergDr Patrick Porter Support the showFollow Steve's socials: Instagram | LinkedIn | YouTube | Facebook | Twitter | TikTokSupport the show on Patreon:As much as we love doing it, there are costs involved and any contribution will allow us to keep going and keep finding the best guests in the world to share their health expertise with you. I'd be grateful and feel so blessed by your support: https://www.patreon.com/MadeToThriveShowSend me a WhatsApp to +27 64 871 0308. Disclaimer: Please see the link for our disclaimer policy for all of our content: https://madetothrive.co.za/terms-and-conditions-and-privacy-policy/

Al Hakam Inspire - Episode 17 Genomics and Precision Health by Voice of Islam

A childhood shaped by loss, discipline, and perseverance — and a life rebuilt through purpose. In this deeply personal episode of Everything Is Personal, Len May sits down with Newton Zang to explore how early adversity, elite athletic discipline, and faith shaped his journey as an entrepreneur and leader. Newton shares powerful stories about growing up as an immigrant, losing his mother at a young age, being raised by a single father, and learning resilience through years of elite sports training. From losing early tournaments to facing repeated rejection, Newton explains how discipline, resourcefulness, and community helped him persevere — both in business and in life. This conversation dives into mental health, trauma, faith, entrepreneurship, failure, and the importance of safe communities where vulnerability becomes strength. EndoDNA: Where Genetic Science Meets Actionable Patient CareEndoDNA bridges the gap between complex genomics and patient wellness. Our patented DNA analysis platforms and AI technology provide genetic insights that support and enhance your clinical expertise.Click here to check out to take control over your Personal Health & Wellness Connect with EndoDNA on SOCIAL: IG | X | YOUTUBE | FBConnect with host, Len May, on IG Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Recorded live at HLTH, this episode of Bright Spots in Healthcare features Dr. Carolyn Jasik, Associate Chief Clinical Officer at Verily, an Alphabet company focused on precision health innovation at scale. Carolyn shares how Verily has evolved through multiple "moonshot" phases, from devices and research to its current focus on precision health, combining AI, data science, and clinical expertise to deliver the right intervention to the right person at the right time. Drawing from her background as a pediatrician, behavioral scientist, and former digital health executive, Carolyn explains why healthcare transformation must move beyond the clinic and into people's daily lives, meeting them in moments that actually matter. In this conversation, you'll hear about: What precision health really means beyond the buzzword, and why timing and context are everything How Verily Me enables consumers to interact with their health records, ask questions, and identify gaps in care The role of AI coaches and human clinicians working together, not in competition Why Verily is taking a direct-to-consumer-first approach to crack the engagement problem in healthcare How licensed nurses, HIPAA-protected AI, and real-time support can transform patient experience Carolyn's long-term vision for AI agents like Violet to meaningfully extend care teams and reduce clinician burden This episode offers a thoughtful, human-centered look at how AI can help people feel seen, supported, and cared for while laying the foundation for scalable, enterprise-grade precision health. If you're building, buying, or deploying digital health solutions, this conversation provides a grounded blueprint for what consumer trust, engagement, and impact really require. Bio: https://hlth.com/speakers/2024/carolyn-bradner-jasik References: Verily Me - https://www.verilyme.com/ Partner with Bright Spots Ventures: If you are interested in speaking with the Bright Spots Ventures team to brainstorm how we can help you grow your business via content and relationships, email hkrish@brightspotsventures.com About Bright Spots Ventures: Bright Spots Ventures is a healthcare strategy and engagement company that creates content, communities, and connections to accelerate innovation. We help healthcare leaders discover what's working, and how to scale it. By bringing together health plan, hospital, and solution leaders, we facilitate the exchange of ideas that lead to measurable impact. Through our podcast, executive councils, private events, and go-to-market strategy work, we surface and amplify the "bright spots" in healthcare—proven innovations others can learn from and replicate. At our core, we exist to create trusted relationships that make real progress possible. Visit our website at www.brightspotsinhealthcare.com. Visit our website:  www.brightspotsinhealthcare.com. Follow Bright Spots in Healthcare: https://www.linkedin.com/company/shared-purpose-connect/

Standard blood work might tell you everything looks “normal,” while your hormones are actually in post-menopausal free fall. In this episode, I'll walk you through my wife Sage's hormone test results on the whiteboard, exposing the hormonal ratios blood tests miss, estradiol being 100x more potent than other estrogens, and why hormone therapy is the only approach that actually works. This episode is essential viewing for couples navigating the hormonal minefield together, complete with the exact protocols that brought Sage back to herself.  CLICK HERE TO BECOME GARYS VIP!: https://bit.ly/4ai0Xwg See Sage's Exact Lab Panel for Precision Health: https://bit.ly/3L1kE3m  Get Tested with the 10x Female Blood Hormone Panel: https://bit.ly/48TL66N  Connect with Sage Workinger-Brecka Instagram: https://bit.ly/44sN390 Thank you to our partners H2TABS: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4hMNdgg BODYHEALTH: “ULTIMATE20” FOR 20% OFF: http://bit.ly/4e5IjsV BAJA GOLD: "ULTIMATE10" FOR 10% OFF: https://bit.ly/3WSBqUa COLD LIFE: THE ULTIMATE HUMAN PLUNGE: https://bit.ly/4eULUKp WHOOP: JOIN AND GET 1 FREE MONTH!: https://bit.ly/3VQ0nzW AION: “ULTIMATE10” FOR 10% OFF: https://bit.ly/4h6KHAD A-GAME: “ULTIMATE15” FOR 15% OFF: http://bit.ly/4kek1ij PEPTUAL: “TUH10” FOR 10% OFF: https://bit.ly/4mKxgcn CARAWAY: “ULTIMATE” FOR 10% OFF: https://bit.ly/3Q1VmkC HEALF: 10% OFF YOUR ORDER: https://bit.ly/41HJg6S RHO NUTRITION: “ULTIMATE15” FOR 15% OFF: https://bit.ly/44fFza0 GOPUFF: GET YOUR FAVORITE SNACK!: https://bit.ly/4obIFDC GENETIC METHYLATION TEST (UK ONLY): https://bit.ly/48QJJrk GENETIC TEST (USA ONLY): ⁠https://bit.ly/3Yg1Uk9 Watch  the “Ultimate Human Podcast” every Tuesday & Thursday at 9AM EST: YouTube: https://bit.ly/3RPQYX8 Podcasts: https://bit.ly/3RQftU0 Connect with Gary Brecka Instagram: https://bit.ly/3RPpnFs TikTok: https://bit.ly/4coJ8fo X: https://bit.ly/3Opc8tf Facebook: https://bit.ly/464VA1H LinkedIn: https://bit.ly/4hH7Ri2 Website: https://bit.ly/4eLDbdU Merch: https://bit.ly/4aBpOM1 Newsletter: https://bit.ly/47ejrws Ask Gary: https://bit.ly/3PEAJuG Timestamps 00:00 Intro of Show 02:11 Sage and Gary's Menopausal Journey 05:16 Effects of Menopause (Frozen Shoulder, Brain Fog, Exhaustion) 12:31 Benefits of Hormone Replacement Therapy 19:18 Results of Sage's Dutch and Wellness Tests 23:58 Link of Catecholamines and Anxiety 27:37 Sage's Dutch Test Results in Visual 43:42 Debunking of the Hormone Therapy and Breast Cancer Connection Study: https://bit.ly/4quZqdt 51:17 Effects after the Hormone Therapy 54:05 Timing of Hormones: https://bit.ly/48UF9Xw 57:49 Other Recommendations from Sage's Health Journey 1:07:15 Connect with Sage 1:08:03 What does it mean to you to be an Ultimate Human? The Ultimate Human with Gary Brecka Podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The Content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Learn more about your ad choices. Visit megaphone.fm/adchoices

Jason Moore, Chair of the Department of Computational Biomedicine and Director of the Center for Artificial Intelligence Research and Education (CAIRE) at Cedars-Sinai Medical Center in Los Angeles, CA, speaks with Pitt's HexAI podcast host, Jordan Gass-Pooré, about his work, the strategic investments his center is making in technology and specialized human expertise to support advanced AI research and about the incorporation of AI and AI agents into precision health.They speak in depth about the recent and rapid emergence of agentic AI, which is expected to have a significant impact on healthcare and how his team's work is advancing the field. They also touch on vetting, deploying, and monitoring AI models for clinical use; explainable AI, trust, and transparency; using AI chatbots to improve the patient experience; the importance of building effective collaborations between industry and academia; and Cedar-Sinai's new PhD program in Health AI.

Dr. Carole Keim welcomes Dr. David Tegay, DO, to The Baby Manual to talk about genetics, the different types of testing and screening involved in genetics, and how it's a key part of pediatric medicine. Dr. Tegay was in residency when he encountered a patient who required a consult from a clinical geneticist from Mount Sinai, and the experience fascinated him so much that he moved from his internal medicine residency to a fellowship in genetics. He discusses all aspects of his field with Dr. Keim. One of the first things Dr. Tegay explains about genetic testing is that most genetic tests are no different than other routine laboratory testing, using a blood sample or even a non-invasive cheek swab or saliva sample to do the testing. It's the results that are different from other testing. He and Dr. Keim discuss how prenatal genetic testing has developed, what kind of screening might occur during pregnancy, and the types of conditions a geneticist may be looking for. Dr. Tegay sheds light on the truth of birth defects, or congenital anomalies, and how frequently they may occur, including how many are not necessarily significant. The conversation exploring DNA, genetics, and exome sequencing, and the diseases or conditions such testing may reveal, is both enlightening and informative, explaining methodology and treatment for fetal and newborn ailments.Dr. David Tegay, DO, FACMG, FACOI:Dr. David Tegay, DO, is a clinical geneticist in Great Neck, NY and has over 25 years of experience in the medical field. He specializes in the areas of Clinical Genetics and Genomics & Internal Medicine. Dr. Tegay graduated from New York Institute of Technology College of Osteopathic Medicine in 1997. He is affiliated with the medical facilities North Shore University Hospital and St. Mary's Hospital Amsterdam.__ Resources discussed in this episode:The Holistic Mamas Handbook is available on AmazonThe Baby Manual is also available on Amazon__Contact Dr. Carole Keim MDlinktree | tiktok | instagram Contact Dr. David Tegay, DO, FACMG, FACOIlinkedin

Introducing Melissa Smith, PharmD, CPH, CPGx, Founder of Florida PGX Consulting, and the new host of the Precision Health and PGX Podcast! Dr. Melissa is joined by her guests Dr. Jamie Wilkey & Dr. Jackie Boyle to discuss their introduction to precision medicine in PGX, as well as their friendship that encouraged it!

What if medicine worked to get you healthier overall—not just people like you or for one or another symptom? In the latest episode of TGen Talks, host Karie Dozer sits down with Nicholas Schork, Ph.D., and Laura Goetz, M.D., co-authors of a recent commentary published in Nature Communications, From Precision Interventions to Precision Health, to explore the promise—and complexity—of truly personalized healthcare. Traditional medicine treats symptoms. Precision healthcare, however, rethinks that model entirely. By tapping into genomics, environment, lifestyle, and even real-time data from wearable devices, Drs. Schork and Goetz discuss developing highly individualized approaches that don't just treat illness—they aim to prevent it. Together, they unpack how this shift could redefine everything from how drugs are tested, to how diseases are managed, and even how we define “health.” They discuss cutting-edge innovations like anti-sense oligonucleotides—drugs custom-made for an individual's genetic code—and the rise of geroprotectors, compounds designed to support whole-body wellness as we age. They discuss the difficulties of such specific treatments and the differences in the way different patients might metabolize and respond to the same medicine. The future of medicine isn't one-size-fits-all. It's N-of-1—and it might just be closer than you think.

Hello Redlo WomenWant to heal your body & reverse your biological age?Meet Roxeanne Hardenburg - a Longevity and Precision Health Hacking Specialist, and the Founder of Essential Farmaceuticals.After living with 15 complex health conditions, and being denied medical intervention during lockdown in 2020, Roxeanne pulled herself up by her courageous bootstraps and healed herself, using her 25 years of experience in IT to track and map data.Learn how she did it!Today, she guides individuals, around the globe, take back control of their healt with her Bounceback Body Blueprint™ - a system that combines DNA-based analysis and botanical biohacking.Keep stepping forward!CONNECT WITH ROXEANNE:Get Your FREE Health ResetLinkedInLinktreeCONNECT WITH TERRI-Click hereTake the FREE Reinvention QuizFacebookGet on the SPEAK waitlistGet Terri's book, Step ForwardTerri❤️

Animal behaviorist and physiologist Carly Anne York shows how unappreciated, overlooked, and simply curiosity-driven science has led to breakthroughs big and small. Then, Sai Krupa Das, a senior scientist in nutrition and aging at Tufts University, and Reyna Gobel, a nutritionist and science journalist, discuss precision medicine and nutrition and an 8,000-person study by the Nutrition for Precision Health that examines how individuals respond to different foods.

Michael Strange has a healthy appreciation for complexity, diagnoses hype as antithetical to innovation and prescribes an interdisciplinary approach to making AI well.  Michael and Kimberly discuss whether AI is good for healthcare; healthcare as a global system; radical shifts precipitated by the pandemic; why hype stifles nuance and innovation; how science works; the complexity of the human condition; human well-being vs. health; the limits of quantification; who is missing in healthcare and health data; the political-economy and material impacts of AI as infrastructure; the doctor in the loophole; the humility required to design healthy AI tools and create a resilient, holistic healthcare system. Michael Strange is an Associate Professor in the Dept of Global Political Affairs at Malmö University focusing on core questions of political agency and democratic engagement. In this context he works on Artificial Intelligence, health, trade, and migration. Michael directed the Precision Health & Everyday Democracy (PHED) Commission and serves on the board of two research centres: Citizen Health and the ICF (Imagining and Co-creating Futures). Related Resources If AI is to Heal Our Healthcare Systems, We Need to Redesign How AI Is Developed (article): https://www.techpolicy.press/if-ai-is-to-heal-our-healthcare-systems-we-need-to-redesign-how-ai-itself-is-developed/ Beyond ‘Our product is trusted!' – A processual approach to trust in AI healthcare (paper) https://mau.diva-portal.org/smash/record.jsf?pid=diva2%3A1914539 Michael Strange (website): https://mau.se/en/persons/michael.strange/  A transcript of this episode is here.     

“Until we address our entire environment and culture, I think we're going to keep seeing complex chronic illnesses on the rise.” - Shefaly RavulaOverall health begins in the gut, and many of our clients dealing with endometriosis and chronic pelvic pain also struggle with gut health challenges that can significantly impact their quality of life. Optimizing their gut health requires us to expand our focus beyond diet and take a root cause approach that explores emotional and physiological factors, like nervous system regulation, environmental toxins, and movement.As health coaches, we're in the best position to help our clients navigate their health challenges with a whole-body approach. We can empower patients in ways conventional GI often misses, like reconnecting with food and transforming it from a source of fear into a source of joy and nourishment. Shifts like this not only result in better nutrition but also support the nervous system and nurture the emotional aspects essential for long-term healing.Today, I'm excited to introduce you to Shefaly Ravula, a physician assistant specializing in gut health. For those of us in women's pelvic health, it's important for us to connect with colleagues in GI health, like Shefaly, who has a unique approach that integrates her conventional background with functional medicine, culinary medicine, and herbal medicine.In this conversation, Shefaly and I discuss the critical link between gut health and overall health, the overlap for many clients between conditions like endometriosis and gut imbalances, Shefaly's journey into functional medicine, why a personalized approach to gut healing is crucial, the importance of nutrition and stress management, why a positive relationship with food matters, strategies for combining medical, emotional, and lifestyle factors to achieve overall wellness, and more.Enjoy the episode, and let's innovate and integrate together!---Learn more or watch the video version of this conversation at https://integrativewomenshealthinstitute.com/functional-medicine-precision-health-culinary-nutrition-with-shefaly-ravula-pa-c/.Connect with me and access our entire platform at IntegrativeWomensHealthInstitute.com (https://integrativewomenshealthinstitute.com/). Find and follow us @integrativewomenshealth on YouTube (https://www.youtube.com/@integrativewomenshealth) and Instagram (https://www.instagram.com/integrativewomenshealth/).

Michael R. Sherer explores the connection between stress, resilience, and redox health. Learn how to manage stress and enhance your resilience through precision health strategies for optimal well-being. #StressManagement #Resilience #PrecisionHealth

In this episode, we discuss everything about ACL injuries. We explore: Role of biomechanics of ACL injuryAre current ACL injury prevention programs effective? Use of Functional MRI in ACL rehabilitationWhat are the long-term consequences of ACL reconstruction? Injury risk post ACL reconstructionWant to learn more about ACL Injury incidence and prevention? Matthew Bourne and Tyler Collings recently did a brilliant Masterclass with us called “Mastering ACL Injury: From Incidence to Injury Prevention” where they go into further depth on this topic. 

On New York University Week:  Reducing the rising rate of preterm births is an important goal for the future. Laura Jelliffe-Pawlowski, professor of epidemiology and precision health at the Rory Meyers College of Nursing, looks into the data to find solutions. Dr. Laura Jelliffe-Pawlowski is a Professor of Epidemiology and Precision Health at NYU Rory […]

Discussion of the Body's Generic Response to Stress, Including Sickness Behaviors and Their Connection to Various Health Conditions with Michael R. Sherer

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, and Dr. Angela Cassano, PharmFusion Founder and owner, discuss Dr. Cassano's personal pharmacogenomics testing and how the results impacted her breast cancer treatment, the tamoxifen and CYP2D6 pharmacogenomics clinical utility research currently available, whether CYP2D6 testing for patients prior to tamoxifen is National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) recommended, and whether insurers in the United States reimburse the testing. This is a must listen for those interested in the clinical pharmacogenomics' current landscape and a pharmacist-patient's perspective about PGx testing.   

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, and Dr. Angela Cassano, PharmFusion Founder and owner, discuss Dr. Cassano's personal pharmacogenomics testing and how the results impacted her breast cancer treatment, the tamoxifen and CYP2D6 pharmacogenomics clinical utility research currently available, whether CYP2D6 testing for patients prior to tamoxifen is National Comprehensive Cancer Network (NCCN) and American Society of Clinical Oncology (ASCO) recommended, and whether insurers in the United States reimburse the testing. This is a must listen for those interested in the clinical pharmacogenomics' current landscape and a pharmacist-patient's perspective about PGx testing.   

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, CEO of inGENEious RX Incorporated Pharmacogenomics Consulting, and Dr. Megan Landsverk, Scientific Director of MolDX® and Chief Science Officer of Palmetto GBA®, discuss how laboratories may overcome the challenges they face earning MolDX® coverage and reimbursement for their clinical pharmacogenomics tests. Specific to coverage determinations, the PGx veterans discuss test design, post-genotype translations, and technical assessments. Specific to reimbursement, the duo discusses evidence-based reporting and complete claim submissions. Also discussed is the importance of labs clearly defining intended use populations for tests and academic partnerships importance when labs develop and validate panels including drug-gene pairs the Clinical Pharmacogenetics Implementation Consortium and the United States Food and Drug Administration does not recognize as clinically utile for managing medications. Dr. Megan Landsverk is a Science Officer for Palmetto GBA, a Medicare Administrative Contractor (MAC) and a Science Director for the Molecular Diagnostic Services (MolDX) program developed to identify and establish coverage and reimbursement for molecular diagnostic services on behalf of Medicare. Dr. Landsverk received her PhD in Biochemistry and Molecular Biology from Baylor College of Medicine and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified Molecular Geneticist, completing her molecular genetics fellowship at Baylor College of Medicine. She has held multiple academic faculty positions and has numerous publications in the field of genetics. Prior to joining Palmetto, she served as a clinical laboratory director in academic, hospital, and commercial clinical laboratories and has experience in several genetic specialties including rare disease (pediatric and adult), cancer (somatic and inherited), and pharmacogenetics.

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, CEO of inGENEious RX Incorporated Pharmacogenomics Consulting, and Dr. Megan Landsverk, Scientific Director of MolDX® and Chief Science Officer of Palmetto GBA®, discuss how laboratories may overcome the challenges they face earning MolDX® coverage and reimbursement for their clinical pharmacogenomics tests. Specific to coverage determinations, the PGx veterans discuss test design, post-genotype translations, and technical assessments. Specific to reimbursement, the duo discusses evidence-based reporting and complete claim submissions. Also discussed is the importance of labs clearly defining intended use populations for tests and academic partnerships importance when labs develop and validate panels including drug-gene pairs the Clinical Pharmacogenetics Implementation Consortium and the United States Food and Drug Administration does not recognize as clinically utile for managing medications.  Dr. Megan Landsverk is a Science Officer for Palmetto GBA, a Medicare Administrative Contractor (MAC) and a Science Director for the Molecular Diagnostic Services (MolDX) program developed to identify and establish coverage and reimbursement for molecular diagnostic services on behalf of Medicare. Dr. Landsverk received her PhD in Biochemistry and Molecular Biology from Baylor College of Medicine and postdoctoral training in Medical Genetics at the University of Washington. She is a board-certified Molecular Geneticist, completing her molecular genetics fellowship at Baylor College of Medicine. She has held multiple academic faculty positions and has numerous publications in the field of genetics. Prior to joining Palmetto, she served as a clinical laboratory director in academic, hospital, and commercial clinical laboratories and has experience in several genetic specialties including rare disease (pediatric and adult), cancer (somatic and inherited), and pharmacogenetics.

Michael R. Sherer explores the connection between stress, resilience, and redox health. Learn how to manage stress and enhance your resilience through precision health strategies for optimal well-being. #StressManagement #Resilience #PrecisionHealth

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Equitable biomarker testing access, including pharmacogenomics testing, is critical for patients to experience optimal medication therapy outcomes. Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Hilary Goeckner, Director of State & Local Campaigns - Access to Care of the American Cancer Society Cancer Action Network (ACS CAN), educate listeners about ACS CAN's mission, how it executes on its mission, accomplishments, and future goals.  This episode is a must listen for anyone who wants the latest update on the American Cancer Society Cancer Action Network's work influencing state legislatures to pass legislation to expand coverage of biomarker testing, states who have already passed legislation and those with pending legislation, and to learn how they too can advocate.   After listening to this episode, listeners will be able to describe biomarker testing's importance in healthcare; describe how the American Cancer Society Cancer Action Network is championing biomarker testing coverage legislation; name states that have passed biomarker testing legislation and those with pending legislation; know how one can contribute to the efforts to increase biomarker testing coverage. Hilary Gee Goeckner is director of state and local campaigns for the American Cancer Society Cancer Action Network (ACS CAN), the advocacy affiliate of the American Cancer Society. In this role she leads work with ACS CAN staff and coalition partners across the country to improve access to comprehensive biomarker testing, clinical trials, fertility preservation and other health care access issues. Prior to this role, Hilary served as the Kansas government relations director for ACS CAN. Before joining ACS CAN, Hilary served as director of health policy at Kansas Action for Children. She holds a bachelor's degree in anthropology and global health from Williams College and a master's degree in social work from Boston College. She lives in San Diego with her husband and two children. As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.  

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Josiah Allen, and Dr. Jeffrey Bishop, three PharmDs and pharmacogenomics industry veterans, discuss hot topics in the PGx industry today including the Board of Pharmacy Specialties exploring the need to establish a pharmacogenomics board specialty for pharmacists, the American Psychiatric Association's and American Heart Association's recent statements on pharmacogenomics' clinical utility, and how the need for PharmDs who are experts in genomic medicine will continue to grow as whole genome sequencing reveals additional druggable biomarkers.  

933: Through advanced data and AI, healthcare companies are transforming care with precision health, delivering earlier diagnoses and personalized treatments. At Illumina, CIO Carissa Rollins is leading the charge, modernizing the tech stack to power the future of precision health. In this episode of Technovation, Carissa discusses how technology is reshaping genomics, sharing her efforts to streamline IT, foster AI innovation, and tackle global challenges like cancer and rare diseases. Host Peter High explores Carissa's journey to becoming a CIO, her leadership in change management, and her vision for advancing precision health.

  DEXA scans promise to reveal the secrets of your body, measuring bone density, fat, and lean muscle with pinpoint accuracy. But do they work? This is a Biohacking Reviews episode. We review; products, supplements, health tech, practices... whatever is new and whatever we've been trying.  Joining me is Tim Gray again after his appearance on our Biohack Of The Year show. Follow him at @timbiohacker on instagram and get tickets to join both me and Tim at The Health Optimisation Summit in Austin.  

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

Be sure to tune in to this episode of the Precision Health and PGX Podcast as Dr. Becky Winslow, Dr. Behnaz Sarrami, and Dr. Jeremy Stuart, Chief Scientific Officer and laboratory director for Precision Genetics, discuss pharmacists value as employees in clinical pharmacogenomics testing laboratories. Having employed pharmacists in his laboratories, Dr. Stuart will provide his first-hand examples to illustrate how pharmacists have benefited his laboratories. Dr. Winslow and Dr. Sarrami will also share their real-world experiences working for clinical pharmacogenomics laboratories to help the laboratory achieve its goals. This episode is a must listen for laboratories who are vested in their pharmacogenomics testing's financial success.  After listening to this episode, the learner will be able to describe responsibilities and roles in pharmacogenomics pharmacists fulfill in clinical labs, name specific real-world examples that illustrate pharmacists' contributions to pharmacogenomics in the clinical laboratory, and name education, training, and work experiences that prepare pharmacists to assume advanced practice roles in clinical laboratories.   Dr. Jeremy Stuart has extensive experience in the life science industry. He specializes in commercial operations, technology development and transfer, manufacturing design, and validation of laboratory developed tests (LDTs). He currently serves as the Chief Scientific Officer for Precision Genetics and serves as their Laboratory Director.  Dr. Stuart was part of the senior management team that completed a management buyout of Lab21 Inc. to form Selah Genomics and the subsequent sale of Selah to EKF. Dr. Stuart led the development and validation of all of Selah's molecular assays and oversaw their clinical studies. Dr. Stuart was also a member of the Agencourt Personal Genomics team, where he co-developed the SOLiD next-generation sequencing technology that was subsequently acquired by Applied Biosystems.   Before entering industry, Dr. Stuart completed his postdoctoral work at the the Harvard School of Public Health, earned his master's degree in Toxicology from the University of Minnesota, and his doctorate in Genetics & Complex Diseases from Harvard University.  As the CEO of inGENEious RX Incorporated and pharmacogenomics subject matter expert, Dr. Becky Winslow has dedicated over a decade to providing innovative solutions for pharmacogenomics stakeholders. Her extensive experience also includes directing pharmacy operations and medication safety programs across diverse clinical settings, spanning retail, hospital, long-term care, and public health. Dr. Winslow is a passionate educator, training Doctors of Clinical Pharmacy to work with molecular testing stakeholders and serving as an advanced pharmacy practice preceptor for Manchester University's Master of Science in Pharmacogenomics Program. She hosts an evidence-based educational podcast, The Precision Health and PGx Podcast, which Welp Magazine recognized as the ninth most listened to genetics podcast globally. Her involvement with prominent organizations like the Clinical Pharmacogenetics Implementation Consortium and the National Council for Prescription Drug Programs (NCPDP) PGx Task Force speaks to her expertise and commitment. Dr. Winslow frequently presents at national conferences such as The Association for Molecular Pathology and holds degrees from Campbell University.  Behnaz Sarrami, PharmD, MS, is a leading expert in pharmacogenomics and a dedicated Medical Science Liaison (MSL). She is named American Pharmacists Association's (APhA) "50 Most Influential Leaders in Pharmacy" and Medika's "Top 30 Women Transforming Healthcare". Behnaz is passionate about advancing personalized medicine to optimize treatments and improve patient outcomes, especially in underserved populations. She supports healthcare professionals through scientific training and presentations. As the host of the "Precision Health and PGx" podcast, she mentors pharmacists transitioning into MSL roles and those launching pharmacogenomics consulting careers. She earned her Master's in Biochemistry from Georgetown University and her Doctorate in Pharmacy from Creighton University. With significant contributions to research and education, she continues to drive innovation in pharmacogenomics through her work with healthcare professionals and community outreach programs.

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over eleven years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Kentucky Teachers' Retirement System, GenXys, and Thermo Fisher Scientific.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, has authored PGx payer databases and billing and coding algorithms and served Mintz Law as the expert medical necessity reviewer of Medicare PGx claims. She is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Winslow is an Advanced Pharmacy Practice Experience preceptor for Manchester University School of Pharmacy PharmD/Masters in PGx students and a registered trainer for the University of Pittsburgh's Test2Learn (TM) Community PGx Certificate Program. Dr. Winslow is a member of the Clinical Pharmacogenetics Implementation Consortium, the NCPDP PGx Task Force, and the Get the Medications Right Institute.  In 2021, Welp Magazine recognized Dr. Winslow's podcast, the PGx for Pharmacists Podcast, as the world's ninth most listened-to genetics podcast. Her podcast shares the top 20 most listened-to genomics podcast list with genomics podcasts created by such notable podcasters as the National Cancer Institute and the American Heart Association. The Pharmacy Podcast Network recognized Dr. Winslow in 2021 as a Top 50 pharmacy influencer. Entities frequently recruit Dr. Winslow to present PGx topics. She has presented at conferences for the National Association of Boards of Pharmacy, the National Association of Specialty Pharmacy, the Inovalon Customer Congress, and the Association for Molecular Pathology and on the Labroots' and Precision Medicine Institute's platforms.  Dr. Winslow earned her Bachelor of Science in Biology and Doctor of Clinical Pharmacy degrees from Campbell University. Lexi Wensel is a 2024 Manchester University School of Pharmacy graduate where she earned her Doctorate in Pharmacy and Masters in Pharmacogenomics. When this episode was recorded in April 2024, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy. While studying to become a pharmacist, Lexi gained practical clinical pharmacy experience while working as a pharmacy intern at both Meijer pharmacy and Marion Health Hospital.   Beyond her academic and professional endeavors, Lexi is deeply committed to giving back to the community. She serves as a board member for an organization called Guatemala Family Development where she contributed to initiatives aimed at improving healthcare access and promoting wellness in underserved communities. At the time this episode was recorded, Lexi was completing an advanced pharmacy practice experience with Dr. Becky Winslow, preceptor for Manchester University School of Pharmacy.  Dr. Mary Weissman is a clinical pharmacogenomics specialist and inGENEious RX Incorporated consultant. Since earning her Doctor of Pharmacy degree from Arnold and Marie Schwartz College of Pharmacy and completing a two-year pharmacogenomics fellowship in a clinical laboratory's medical affairs department, Dr. Weissman has applied her pharmacogenomics expertise in clinical diagnostic laboratories. At those laboratories, she has scientifically, and clinically supported pharmacogenomics stakeholders to increase clinical pharmacogenomics implementation into clinical settings. Holding titles such as clinical scientist, she has authored and developed medical content to educate healthcare providers and patients about pharmacogenomics and authored clinical decision support tools prescribers use to leverage pharmacogenomic insights in medication therapy management. Through educational trainings, white papers, presentations, and webinars, she has clarified pharmacogenomics' complexities and helped move pharmacogenomics toward a standard of care.  

In this transformative episode of Building Billions, I'm joined by Ben Greenfield, one of the world's foremost experts in biohacking and human performance. We're diving deep into a revolutionary approach to health optimization with 10X Health's precision supplements, cutting-edge genetic insights, and targeted protocols that are changing the way we think about nutrition, recovery, and personal wellness. Ben has tried it all, but what he's discovering with this precision-based system is next-level—and today, we're sharing how it can help you perform, feel, and live at your best. Throughout the conversation, Ben explains how customized nutrition, precise supplement routines, and real-time biomarker tracking can simplify and amplify your wellness. Imagine an IV drip tailored just for your body's needs or supplements built from your unique genetic profile—all in service of supercharging your energy, eliminating guesswork, and putting you back in control of your health. Ben and I discuss the freedom that comes with this streamlined system, from ditching supplement overload to traveling with only what your body actually needs to perform at its peak. If you're looking to take your wellness to a new level, this episode is a powerful entry point. Join us as we explore how personalized health can be scalable and accessible, from optimizing your day-to-day to building a foundation of health that supports long-term goals. This is about more than just feeling better; it's about creating a life where health fuels every move you make.Support the show: http://cardoneventures.comSee omnystudio.com/listener for privacy information.

Welcome back to Building Billions, I'm Brandon Dawson. I am joined by my partner Sarah Lomas, founder and CEO of REVIV Global.  In this episode, we dive into how 10X Health and REVIV Global are revolutionizing healthcare by combining personalized data, science, and technology to create tailored health solutions. Sarah shares how her vision began in 2013, starting with IV therapy, and the journey of transforming it from a niche treatment into a global modality now accessible in 46 countries. If you're looking to take control of your health and optimize your well-being, this episode will show you how precision nutrition can transform your life and change the world. With data-backed solutions and a proven system. Anyone can access personalized health strategies that improve overall wellness and longevity. As always, make sure to leave a review and share this episode with your friend & colleagues!Support the show: http://cardoneventures.comSee omnystudio.com/listener for privacy information.

Save 20% on all Nuzest Products WORLDWIDE with the code MIKKIPEDIA at www.nuzest.co.nz, www.nuzest.com.au or www.nuzest.comThis week on the podcast Mikki speaks to epidemiologist Dr Terry Boyle about cancer risk and exercise. They discuss the increase in cancer cases worldwide and what might be at the heart of the increasing prevalence. They talk about how exercise can help reduce risk of cancer, but also how it can help an individual throughout their treatment and what the research tells us about its importance. They also discuss sedentary behaviour, what it means to be sedentary and why this increases the risk of cancer in the general population. And much more.https://people.unisa.edu.au/Terry.BoyleDr Terry Boyle is an epidemiologist in the Australian Centre for Precision Health at UniSA. He has a broad interest in lifestyle factors and chronic disease, with a focus on the role that physical activity and sedentary behaviour play in cancer risk, cancer survival and cancer survivorship. While he conducts research on a range of cancers, his recent studies have been on haematological cancers such as non-Hodgkin lymphoma.Terry received his PhD from The University of Western Australia in 2012, then received prestigious Fellowships from the Australian National Health and Medical Research Council (NHMRC) and the Canadian Institutes for Health Research (CIHR) which gave him the opportunity to spend two years at the BC Cancer Agency and the University of British Columbia in Vancouver, Canada. He joined UniSA in October 2017, before which he was at the Curtin University School of Public Health in Western Australia.Terry has experience in a range of epidemiological and biostatistical methods, including multiple imputation, meta-analysis, directed acyclic graphs, causal inference methods, assessment of lifestyle-related and occupational exposures and increasing participation in epidemiological studies, and is currently leading several projects involving pooling data from multiple national and international studies. Terry also lectures and consults in biostatistics. Curranz Supplement: Use code MIKKIPEDIA to get 20% off your first order - go to www.curranz.co.nz  or www.curranz.co.uk to order yours Contact Mikki:https://mikkiwilliden.com/https://www.facebook.com/mikkiwillidennutritionhttps://www.instagram.com/mikkiwilliden/https://linktr.ee/mikkiwilliden

Ikerian is pioneering the use of non-invasive retinal imaging and AI to identify biomarkers that can predict disease progression and treatment response.

微軟在智慧醫療領域下好大一盤棋？最近釋出的foundation model目標何在？這跟上次講的權重又有何關係？真是項莊舞劍，意在沛公？ 連結： Forbes: https://www.forbes.com/sites/saibala/2024/05/22/microsoft-announces-new-foundation-model-for-digital-pathology-diving-deeper-into-clinical-medicine/ Multimodal Generative AI: the Next Frontier in Precision Health by Hoifung Poon: https://www.youtube.com/watch?v=CGyQxdM2KU8 節目內容： 若晴有要事要更正 Inside Out 2不能暴雷的討論 前情提要，權重是啥？ 對醫療AI的想像 微軟新發布的模型 Foundation model 玻片數位化 醫療填空題 最終的目標是？？？ -- Hosting provided by SoundOn

In this episode of The Root Cause Medicine Podcast, we discuss food intolerances, food allergies, and gut health. They dive into: 1. Food Issues Symptoms 2. Food Allergy Versus Food Sensitivity 3. How Food Affects Your Intestines Dr. James LaValle is an internationally recognized clinical pharmacist, author, board-certified clinical nutritionist, educator in integrative and precision health, and founder of Metabolic Code Enterprises. He has over thirty-five years of experience integrating natural and integrative therapies into various medical and business models. Dr. LaValle has also authored sixteen e-books and twenty books, was named one of the “50 Most Influential Pharmacists” by American Druggist magazine, and was one of only nine Americans selected to serve under Senator Harkin to participate in the inaugural Dietary Supplement Education Alliance & Dietary Supplement Information Bureau.

David Hellerstein, MD, is professor of clinical psychiatry and an award-winning writer of  nonfiction and fiction. Books such as Heal Your Brain: How the  New Neuropsychiatry Can Help You Go from Better to Well (2011); A Family of  Doctors (1994), a memoir of 5 generations of doctors in his family; Battles of Life  and Death, an essay collection; and two novels, Loving Touches and Stone Babies. And recently The Couch, the Clinic, and the Scanner. A must read! A top psychiatric researcher, he has done cutting-edge studies on new treatment  for depression, using MRI imaging to discover brain circuits related to illness and  the effects of treatment. For the past five years, his research has focused on new  psychedelic treatments of depression and other disorders, using psilocybin and  other long-banned drugs.   

May 14: Today on TownHall Sue Schade, Principal at StarBridge Advisors talks with Paul Browne, SVP and Chief Information Officer at Henry Ford Health System. As he shares his journey through the healthcare technology industry and the strategic plan at Henry Ford, key questions surface. How are we redefining patient and workforce engagement in this digital age? How does the idea of 'precision health' disrupt traditional healthcare models and what does this mean in building a more personalized patient-care approach? And importantly, as we innovate healthcare cost structures and experience labor cost rises, how does the role of CIO evolve in terms of workforce development and succession readiness? Subscribe: This Week HealthTwitter: This Week HealthLinkedIn: Week HealthDonate: Alex's Lemonade Stand: Foundation for Childhood Cancer

Episode Summary: In recognition of National DNA Day, April 25, 2024, Dr. Mary Weissman, Miss Courtney Harmon, and Dr. Becky Winslow discuss clinical pharmacogenomics resources, what pharmacogenomics information they provide, and how to navigate and utilize the pharmacogenomics information to answer a prescriber's clinical question about pharmacogenomics' relationship to an adverse drug event.  Listeners interested in learning a step-wise approach to using the Food and Drug Administration's (FDA's) Table of Pharmacogenetics Associations and the FDA Table of Pharmacogenomic Biomarkers in Drug Labeling, the Clinical Pharmacogenetics Implementation Consortium's (CPIC's) database, and the Pharmacogenomics Knowledgebase (PharmGKB) to demystify pharmacogenomics' role in adverse drug events will not want to miss this Precision Health and PGx Podcast episode.  Biographies: Before founding inGENEious RX Incorporated, a boutique pharmacogenomics consulting firm, Dr. Winslow directed pharmacy business operations and clinical pharmacy programs in retail, hospital, long-term care, and public health pharmacies for Walmart Stores, Community Health Systems, Neil Medical Group, and the North Carolina Department of Health and Human Services. Since founding inGENEious RX over ten years ago, Dr. Winslow has worked with numerous distinguished vendors in the pharmacogenomics industry to reduce barriers holding pharmacogenomics back from becoming a standard of care including Translational Software, Admera Health, Genemarkers, National Association of Chain Drug Stores, Acutis Diagnostics, Kentucky Teachers' Retirement System, and GenXys.  A sought-after pharmacogenomics subject matter expert, Dr. Winslow, is an authority in pharmacogenomics access and reimbursement and specializes in business strategy consulting for pharmacogenomics stakeholders.   Dr. Mary Weissman is a pharmacogenomics science, clinical utility and reimbursement expert and inGENEious RX Incorporated team member.  After earning her PharmD from the Arnold and Marie Schwartz College of Pharmacy, Dr. Weissman completed a two-year pharmacogenomics fellowship with a clinical diagnostic lab. Upon completing her academic training in pharmacology and pharmacogenomics, Dr. Weissman embarked on a journey to apply her expertise in clinical diagnostic laboratories and has held several key scientific and clinical roles in pharmacogenomics laboratories. Through informative presentations, training sessions, papers, and webinars, she has helped clarify pharmacogenomics' complexities and highlight its potential to revolutionize medication management strategies for pharmacogenomics' stakeholders. Miss Courtney Harmon is graduating from Manchester University's Pharmacy and Pharmacogenomics programs in 2024.  She serves as a P4 liaison for Manchester University's chapter of Industry Pharmacists Organization (IPhO) and she is interested in pursuing a career in industry pharmacy. She has worked for Walgreens pharmacy for the last eight years.  References: 1. Table of pharmacogenomic biomarkers in drug labeling. U.S. Food and Drug Administration. Published August 10, 2023. Accessed February 1, 2024. https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling  2. Table of pharmacogenetic associations. U.S. Food and Drug Administration. Published October 26, 2022. Accessed February 1, 2024. https://www.fda.gov/medical-devices/precision-medicine/table-pharmacogenetic-associations  3. CPIC. Cpicpgx.org. Accessed February 1, 2024. https://cpicpgx.org  4. PharmGKB. PharmGKB. Accessed February 1, 2024. https://www.pharmgkb.org Keywords: #pharmacogenomics #ingeneiousrx #PGx #pharmacists #precisionhealthandpgxpodcast #pharmacypodcastnetwork #pharmacogenetics #genetics #sources #resources #FDA #CPIC #PharmGKB

Cafer's Psychopharmacology| Dr Jason Cafer is an assistant Professor of Clinical Psychiatry at University of Missouri-Columbia. He is certified by the American Board of Psychiatry and Neurology and also the American Board of Preventive Medicine. In 2007 he founded Iconic Health, a medical informatics startup that obtained angel round funding. He was Principal Investigator for Phase I and II Small Business Innovation Research (SBIR) grants for "Online Rural Telepsychiatry Platform" that was funded by the United States Department of Agriculture. He is the inventor of United States Patent which was the subject of an SBIR grant awarded by the Department of Health and Human Services for "Medication IconoGraphs: Visualization of Complex Medication Regimens". Visit his website to learn more about Cafers' Psychopharmacology. https://www.cafermed.com/blog Behnaz Sarrami, MS, PharmD  Becky Winslow, PharmD  Dr. Jason Cafer, MD  

This week, I am joined by Dr. Lloyd Minor, the Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine and Vice President for Medical Affairs at Stanford University. Dean Minor talks about the transformative potential of AI in healthcare delivery, research, and diagnostics. We discuss its nuanced pros and cons, including impacts on accessibility, safety, and efficiency. Dean Minor examines AI's benefits in drug discovery, Precision Health, and early disease detection. He elaborates on wearables and the shift towards a proactive approach, integrating tools like virtual reality into medical education and emphasizing nutrition in training. Addressing ethical considerations and industry influence, we delve into the regulatory framework driving transformative changes. We also explore groundbreaking diagnostics, envisioning a future revolutionized by growing and 3D printing organs, and much more.  Enjoy! Show notes + MORE Watch on YouTube Newsletter Sign-Up  Today's Sponsors: Brain.fm: Focus music for productivity—listeners can get 30 days FREE 

Towny Robinson is the CEO of JayMac Pharmaceuticals and the inventor of EnLyte and EnBrace HR. He is a national expert on Methylation Biochemistry/Genetics and Psychiatric Disorders. Visit his website to learn more: www.enlyterx.com/about-enlyte www.enlyterx.com/about-enlyte Behnaz Disclaimer: These are my personal views and opinions, and I am not speaking on behalf of Castle Biosciences, Inc.  

This week on the Think Fit Be Fit podcast, Jennifer Schwartz and Angela DalMolin invite Dr. Matt Dawson of Wild Health Diagnostics to discuss the intersection of health, fitness, and cutting-edge technology. Jenn, Angela, and Dr. Dawson discuss the future of medicine, the power of personalized health optimization, and the importance of motivation in achieving optimal results. Dr. Dawson shares his insights on the role of technology and the need for a holistic approach to healthcare. He also touches on the benefits of coaching and accountability in achieving long-term health goalsTopics discussed:Wild Health leverages an individual's DNA, lifestyle data, and AI analytics to personalize health optimization.The company aims to reconnect people with ancient wellness wisdoms while utilizing the latest in health technology.Motivation is a critical factor in achieving significant health outcomes through personalized health plans.Wild Health's upcoming AI app aims to further democratize health optimization by providing personalized advice based on comprehensive personal data.The Think Fit Be Fit podcast focuses on empowering listeners with knowledge and critical thinking to take control of their fitness and health.Wild Health is offering our listeners a discount code for 20% off a subscription WH20 f to their Precision Health services: https://www.wildhealth.com https://www.instagram.com/wildhealthmd/ SUBSCRIBE: Subscribe to the podcast to make sure you never miss an episode.You can find us on a variety of podcast apps:SpotifyPandoraiHeartRadioAmazon MusicTuneInGoogle podcastsConnect with Jennifer Schwartz:Studio websitePersonal WebsiteInstagramTwitterConnect with Angela DalMolin:https://www.instagram.com/rethinking_fitness/Support the Show:Hydrogen is used by health professionals as a powerful antioxidant and the #1 tool to fight inflammation. Studies show therapeutic potential in cancer, diabetes, digestive and heart issues, and essentially every organ and system in the body. Because hydrogen is the smallest...

In this captivating episode of the Thrive State Summit, Dr. Kien Vuu dives deep into the realms of consciousness, human evolution, and transformational leadership with visionary Matt Riemann. They explore the fusion of spirituality, health, and technology, aiming to guide humanity towards its inherent truth and eradicate chronic disease by 2050. Discover the groundbreaking approach of using AI for personalized health insights and how understanding your unique biological makeup can lead to a life of fulfillment and purpose. Don't miss these profound insights and practical tips to embark on your path of conscious evolution.    Check out this amazing AI technology at www.ph360.me/drv   

Episode Highlights With MattWhat wild health is and where this concept came fromHow a return to nature is the root of good healthWhat separates precision medicine from traditional medicineWhy genetics are important but they are only about 20% of the whole pictureThe importance of light, sleep, and stress for healthFactors we can optimize for our kids for lifelong healthAre diseases actually preventableWhat their data says on reversing disease through lifestyle interventionHis core pillars of optimal health and how to optimize each oneWhat studies say about movement and how much we needWhy he is also on team sardines as a superfoodThe reason to look at the calories vs nutrients equationHis personalized non-negotiables for healthWays to improve sleep qualityScience backed reasons to focus more on relationships and connection for better healthResources We MentionWild HealthOura RingChiliSleepLevels - Continuous Glucose MonitorLast Child in the Woods: Saving Our Children From Nature-Deficit Disorder by Richard LouvThe Bible (NIV)Awareness: Conversations with the Masters by Anthony de MelloThe 15 Commitments of Conscious Leadership: A New Paradigm for Sustainable Success by Jim DethmerThanks to Our Sponsors:Wellnesse - My line of personal care products such as toothpaste, deodorant, shampoo and much more!Timeline Nutrition - Mitopure from Timeline Nutrition offers an easy way to get your daily 500mg dose of Urolithin A, which helps with energy and endurance and so much more! Use code wellnessma for a discount.